Literature DB >> 11673266

Expression and redistribution of cellular Bad, Bax, and Bcl-X(L) protein is associated with VCD-induced ovotoxicity in rats.

X Hu1, P Christian, I G Sipes, P B Hoyer.   

Abstract

Previous studies have shown that 4-vinylcyclohexene diepoxide (VCD)-induced ovotoxicity in rats is likely caused by acceleration of the normal rate of atresia (apoptosis). VCD-induced ovotoxicity is specific for small preantral follicles and is associated with increased activity of caspase cascades. The present study was designed to investigate the alteration of expression and distribution of several Bcl-2 family member proteins induced by dosing of VCD in rat small ovarian follicles. Female F344 rats were given a single dose of VCD (80 mg/kg, i.p., 1 day; a time when ovotoxicity is not initiated), or dosed daily for 15 days (80 mg/kg, i.p., 15 days; a time when significant ovotoxicity is underway). Four hours following the final dose, livers and ovaries were collected. Ovarian small (25-100 microm) and large (100-250 microm) preantral follicles were isolated, and subcellular fractions (cytosolic and mitochondrial) were prepared. Compared with controls, levels of the proapoptotic protein, Bad, were greater in both cytosolic and mitochondrial fractions of small preantral follicles collected from 15-day VCD-treated rats (cytosol, 1.97 +/- 0.16; mitochondria, 2.20 +/- 0.24, VCD/control, P < 0.05). After 15 days of daily VCD dosing, total cellular antiapoptotic Bcl-x(L) protein levels were unaffected in small preantral follicles, but its distribution in mitochondrial and cytosolic components was altered (mitochondria, 0.635 +/- 0.08; cytosol, 1.39 +/- 0.14, VCD/control, P < 0.05). Likewise, VCD did not affect protein levels of proapoptotic Bax in small follicles on Day 15. However, consistent with a Bax-mediated mechanism of apoptosis, the relative ratio of Bax/Bcl-x(L) in the mitochondrial fraction of small preantral follicles was significantly increased by VCD dosing (1.62 +/- 0.21, VCD/control, P < 0.05). Immunofluorescence staining intensity evaluated by confocal microscopy visualized cytochrome c protein in the cytosolic compartment in granulosa cells of preantral follicles in various stages of development. Relative to controls, within the population of small preantral follicles, staining intensity was less (P < 0.05) and presumably more diffuse, specifically in stage 1 primary follicles from VCD-treated animals (15 days). VCD caused none of these effects in large preantral follicles or liver (not targeted by VCD). These data provide evidence that the apoptosis induced by VCD in ovarian small preantral follicles of rats is associated with increased expression of Bad protein, redistribution of Bcl-x(L) protein and cytochrome c from the mitochondria to the cytosolic compartment, and an increase in the Bax/Bcl-x(L) ratio in the mitochondria. These observations are consistent with the involvement of Bcl-2 gene family members in VCD-induced acceleration of atresia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11673266     DOI: 10.1095/biolreprod65.5.1489

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  34 in total

1.  Inhibition of PIK3 signaling pathway members by the ovotoxicant 4-vinylcyclohexene diepoxide in rats.

Authors:  Aileen F Keating; Shannon M Fernandez; Connie J Mark-Kappeler; Nivedita Sen; I Glenn Sipes; Patricia B Hoyer
Journal:  Biol Reprod       Date:  2010-11-10       Impact factor: 4.285

Review 2.  Impact of environmental exposures on ovarian function and role of xenobiotic metabolism during ovotoxicity.

Authors:  Poulomi Bhattacharya; Aileen F Keating
Journal:  Toxicol Appl Pharmacol       Date:  2012-04-13       Impact factor: 4.219

3.  Glutathione S-transferase class μ regulation of apoptosis signal-regulating kinase 1 protein during VCD-induced ovotoxicity in neonatal rat ovaries.

Authors:  Poulomi Bhattacharya; Jill A Madden; Nivedita Sen; Patricia B Hoyer; Aileen F Keating
Journal:  Toxicol Appl Pharmacol       Date:  2012-12-27       Impact factor: 4.219

4.  Inhibition of ovarian KIT phosphorylation by the ovotoxicant 4-vinylcyclohexene diepoxide in rats.

Authors:  Connie J Mark-Kappeler; Nivedita Sen; Ashley Lukefahr; Laurel McKee; I Glenn Sipes; John Konhilas; Patricia B Hoyer
Journal:  Biol Reprod       Date:  2011-06-15       Impact factor: 4.285

5.  Estradiol treatment, physical activity, and muscle function in ovarian-senescent mice.

Authors:  Sarah M Greising; Ryan S Carey; Jennifer E Blackford; Laurin E Dalton; Allison M Kosir; Dawn A Lowe
Journal:  Exp Gerontol       Date:  2011-05-04       Impact factor: 4.032

6.  Steroidogenic capacity of residual ovarian tissue in 4-vinylcyclohexene diepoxide-treated mice.

Authors:  Zelieann Rivera; Patricia J Christian; Sam L Marion; Heddwen L Brooks; Patricia B Hoyer
Journal:  Biol Reprod       Date:  2008-10-01       Impact factor: 4.285

7.  Retaining Residual Ovarian Tissue following Ovarian Failure Has Limited Influence on Bone Loss in Aged Mice.

Authors:  Zelieann R Craig; Samuel L Marion; Janet L Funk; Mary L Bouxsein; Patricia B Hoyer
Journal:  J Osteoporos       Date:  2010-06-29

8.  Acute 7,12-dimethylbenz[a]anthracene exposure causes differential concentration-dependent follicle depletion and gene expression in neonatal rat ovaries.

Authors:  Jill A Madden; Patricia B Hoyer; Patrick J Devine; Aileen F Keating
Journal:  Toxicol Appl Pharmacol       Date:  2014-02-24       Impact factor: 4.219

9.  Dioxin exposure reduces the steroidogenic capacity of mouse antral follicles mainly at the level of HSD17B1 without altering atresia.

Authors:  Bethany N Karman; Mallikarjuna S Basavarajappa; Patrick Hannon; Jodi A Flaws
Journal:  Toxicol Appl Pharmacol       Date:  2012-08-06       Impact factor: 4.219

10.  Effect of phosphatidylinositol-3 kinase inhibition on ovotoxicity caused by 4-vinylcyclohexene diepoxide and 7, 12-dimethylbenz[a]anthracene in neonatal rat ovaries.

Authors:  Aileen F Keating; Connie J Mark; Nivedita Sen; I Glenn Sipes; Patricia B Hoyer
Journal:  Toxicol Appl Pharmacol       Date:  2009-08-18       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.